Status:
COMPLETED
A Study to Evaluate the Potential for Interpersonal Transfer of Testosterone Following Single Dose Application
Lead Sponsor:
Acrux DDS Pty Ltd
Conditions:
Hypogonadism
Eligibility:
All Genders
18-45 years
Brief Summary
The hypotheses for this study is that there is no transfer of testosterone from male (donor) subjects to female (recipient) subjects when contact is made 2 hours post application of 2% Testosterone MD...
Eligibility Criteria
Inclusion
- Healthy Male Subjects:
- Inclusion:
- Healthy male subjects aged ≥ 18 and ≤ 45, who have no history of clinically significant medical disorders and who have passed the required laboratory and physical screening tests.
- Exclusion:
- Men with a history of allergy/sensitivity to testosterone or in whom testosterone therapy is contraindicated, or a clinically significant finding on physical exam or skin disorder.
- Healthy Female Subjects:
- Inclusion:
- Healthy premenopausal women aged ≥ 18 and ≤ 45, who have no history of clinically significant medical disorders and who have passed the required laboratory and physical screening tests.
- Exclusion:
- Women with a history of allergy/sensitivity to testosterone or in whom testosterone therapy is contraindicated, or a clinically significant finding on physical exam or skin disorder.
Exclusion
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01172366
Start Date
August 1 2010
End Date
September 1 2010
Last Update
September 6 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QPharm
Brisbane, Queensland, Australia